Conference
An exploratory, randomised, controlled, parallel-group, open-label study to evaluate different dosing regimens of rabeprazole in controlling nocturnal heartburn (NT HB) symptoms in uninvestigated symptomatic gastroesophageal reflux disease (s-GERD)
Authors
Morgan DG; Ganguli SC; O Mahony MF; Roy J; Camacho F; Teixeira B; Husein-Bhabha FA
Volume
130
Pagination
pp. A176-A176
Publisher
W B SAUNDERS CO-ELSEVIER INC
Publication Date
April 1, 2006
Name of conference
Digestive Disease Week/107th Annual Meeting of the American-Gastroenterological-Association
Conference place
Los Angeles, CA
Conference start date
May 19, 2006
Conference end date
May 24, 2006
Conference proceedings
GASTROENTEROLOGY
Issue
4
ISSN
0016-5085